Escitalopram has FDA approval for the treatment of major depressive disorder in adolescents and adults, and generalized anxiety disorder in adults [REF].
In contrast to these findings, a 2011 review concluded that all second-generation antidepressants are equally effective,[REF] and treatment guidelines issued by the National Institute of Health and Clinical Excellence and by the American Psychiatric Association generally reflect this viewpoint [REF].